JAK inhibition ameliorates bone destruction by simultaneously targeting mature osteoclasts and their precursorsShinya Yari, Masaru Ishii, Daisuke Okuzaki et al.|Inflammation and Regeneration|2023Cited by 18
Single-cell transcriptomics of human cholesteatoma identifies an activin A-producing osteoclastogenic fibroblast subset inducing bone destructionKotaro Shimizu, Masaru Ishii, Junichi Kikuta et al.|Nature Communications|2023Cited by 17